Dr. Herbst is Ensign professor of medicine, professor of pharmacology, chief of medical oncology, and associate director for translational research at Yale Cancer Center and Yale School of Medicine. He is a fellow of the American Society of Clinical Oncology and the American College of Physicians and an elected member of the Association of American Physicians.
Dr. Herbst is a pioneer of personalized medicine and immunotherapy to identify biomarkers and bring novel targeted treatments to patients, serving as principal investigator for trials leading to approval of several therapies revolutionizing the field. He has authored more than 300 publications.
The NCI Lung SPORE he leads has identified new mechanisms of sensitivity and resistance to immunotherapy. His work on Lung MAP, has galvanized the field by developing public-private partnerships to conduct large clinical studies. Dr. Herbst is a major proponent of tobacco control and regulation (including e-cigarettes), authoring policy statements and leading Capitol Hill briefings.